Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
STERIS Life Sciences
STERIS Life Sciences
Activities:
Infection Control
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Big names announced for leading Pharma and Cleanroom conference
The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Containment
ChargePoint and STERIS collaborate on fully validated sterile transfer solution
New collaboration has integrated technologies for sterile transfer of drug substances and drug products during biopharmaceutical manufacturing
Packaging
Particulate contamination is a concern for critical product contact surfaces
Data shows that STERIS BPS materials generate a fraction of the particles generated by cellulose based products
Finance
STERIS reports 9% revenue growth
“Fiscal 2020 is shaping up to be a great year,” says CEO on the latest financial report
Manufacturing
How to reduce tableting costs without losing quality or efficiency
Stephen Natoli of Natoli Engineering Company discusses how to reduce costs while maintaining or increasing output and efficiency
Pharmaceutical
Editor’s pick: Must see at Interphex 2018
The who’s and what’s on the show floor at the International Pharmaceutical Expo in New York
Cleaning
STERIS launches Reliance 980PG Pharmaceutical Grade Washer
The washing system provides advanced cleaning assurance for automated washing needs
Subscribe now